France Pharmaceuticals and Healthcare Report Q2 2009 – New Company …
Jun 23rd, 2009 | By French BioBeach | Category: Latests News and AlertsPR-Inside.com (Pressemitteilung) – Wien,Austria
France Biotech’s Drug Pipeline Review, published in March 2009, revealed that funding for the country’s life sciences industry fell to EUR143mn (US$180mn) …
France Pharmaceuticals and Healthcare Report Q2 2009 – New Company …
Posted via email from French BioBeach
Related posts:
- France Set To Lead The Growth Of The European Active Pharmaceuticals Ingredients Market
- European Consumers Share a High Interest in Healthcare, but Hold Varied Views on Many Health Issues
- Bayer names ex-Novartis manager as HealthCare boss
- France Biotech elects new chair to succeed Pouletty
- US biofuel makers want CO2 credits in climate bill – Reuters
